SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001052918-21-000404
Filing Date
2021-12-06
Accepted
2021-12-06 17:02:05
Documents
3
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 AVRICORE HEALTH INC. FORM 6-K avricore6ksept2021.htm 6-K 10049
2 NEWS RELEASE nr_ex99z1.htm EX-99 9690
3 nrex99z1_1.jpg GRAPHIC 7366
  Complete submission text file 0001052918-21-000404.txt   31336
Mailing Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2
Business Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2 604-687-2038
Avricore Health Inc. (Filer) CIK: 0001355736 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-51848 | Film No.: 211473772
SIC: 2834 Pharmaceutical Preparations